Johnny Hu
Principal @ Menlo Ventures
Johnny Hu is a seed investor at Menlo Ventures focused on Health Care and Therapeutics. Johnny Hu is the Principal at Menlo Ventures. He attended Harvard University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Johnny Hu invests in
Stages Johnny Hu invests in
Countries Johnny Hu invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (50%)
- Therapeutics 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Country
- Switzerland 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aurora Therapeutics is reimagining how personalized gene-editing medications are created and approved for patients with rare diseases. | $16M / Seed / Jan 09, 2026 | ||
| Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics. | $38M / Series A / Nov 21, 2022 |
Co-Investors
About Menlo Ventures
Menlo Ventures provides capital for multi-stage consumer, enterprise, and life sciences technology companies. Since 1976, the firm’s market-driven analysis has led to the identification of opportunities and successful investments in innovative markets. Notable areas of investment include Marketplaces (Uber, Rover.com, Poshmark); Consumer Services(Tumblr, Betterment, Roku, Siri); Dev/Ops (Harness, Edge Delta, Fire hydrant); SaaS (Carta, ScoutRFP, Qualia, Benchling, Everlaw); Fintech (Betterment, Bluevine, Chime); Cybersecurity (Cavium, IronPort, BitSight, Abnormal, StackRox); and Life Sciences Technology (Synthego, Cofactor Genomics, Recursion Pharmaceuticals, 3T Biosciences). Menlo’s portfolio includes more than 70 public companies, and more than 100 mergers and acquisitions, with $5 billion under management. The firm is currently investing in Menlo Ventures XV, a $500 million early-stage fund, as well as its $500 million Inflection Fund, which targets early-growth investments.
Menlo Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Henry Montgomery
Founder and Partner Emeritus
|
|||
Jean-Paul Sanday
Partner
|
|||
John Jarve
Partner Emeritus
|
|||
|
Johnny Hu
Principal
|
|||
Steve Sloane
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Johnny Hu invest in?
Johnny Hu invests primarily in Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Johnny Hu?
Public channels for Johnny Hu include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Johnny Hu last invest?
The most recent investment recorded for Johnny Hu closed in Jan 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
